hr breast cancer: pooled analysis from monarch 2 and 3
Published 6 years ago • 266 plays • Length 3:06Download video MP4
Download video MP3
Similar videos
-
3:20
hr breast cancer: prognostic subgroups in monarch trials
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data
-
6:07
hr breast cancer: updated results from monarch trials
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
1:13
overall survival data of the monarch-2 trial in hr /her2- breast cancer
-
2:02
dr. dickler on monarch 1 results in hr /her2- breast cancer
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
1:57
impact of cdk4/6 inhibitors on hr-positive, her2-negative advanced breast cancer
-
5:06
monarch 1: abemaciclib monotherapy for hr mbc
-
8:39
final overall survival analysis of monarch 1
-
5:34
monarch 2: overall survival of abemaciclib plus fulvestrant in hr , her2- advanced breast cancer
-
5:04
abemaciclib fulvestrant at progression of hr mbc
-
1:58
dr. tolaney on presence of pik3ca and esr1 mutations in monarch 2 trial in breast cancer
-
4:45
monarch 3: abemaciclib as initial therapy for patients with hr /her2- advanced breast cancer
-
9:18
monarch 3: abemaciclib with endocrine therapy for mbc
-
2:58
dr. goetz discusses a secondary analysis of the monarch trials in breast cancer
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
2:42
phase ii results for abemaciclib in pretreated hr /her2-negative breast cancer
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...